The timing of sepsis relative to cancer diagnosis also matters: preclinical models demonstrate that sepsis occurring before cancer can accelerate tumor growth through sustained immunosuppression, whereas sepsis after cancer may transiently inhibit tumors via NK cell activation but later drive recurrence through IL-10/PD-L1-mediated immune exhaustion [72]. The gene discussed is CD274; the disease is cancer.